Skip to main content
. 2022 Nov 9;10(6):e01926-22. doi: 10.1128/spectrum.01926-22

FIG 1.

FIG 1

Overview of the experimental workflow for human samples. (A) Gut microbiome analysis using fecal samples from the HC, PTB, and TBM groups. (B) Calculation of cytokine expression levels in plasma samples from the HC, PTB, and TBM groups. (C) Identification of dominant gut bacteria using whole-genome sequencing. HC, healthy control; PTB, patients with pulmonary tuberculosis; TBM, patients with tuberculous meningitis.